Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
509.40
Change Change %
-7.30 -1.41%

Updated:19 Jun, 2019, 15:55 PM IST

BSE
509.50
Change Change %
-6.15 -1.19%

Updated:19 Jun, 2019, 16:01 PM IST

Natco Pharma's Financial Summary

View last 5 years Financial Summary

Parameter MAR'18
(₹ Cr.)
MAR'17
(₹ Cr.)
Change %
Gross Sales 2,108.50 2,002.80 5.28%
Less :Inter divisional transfers 0.00 0.00 0.00%
Less: Sales Returns 0.00 0.00 0.00%
Less: Excise 17.20 44.80 -61.61%
Net Sales 2,091.30 1,958.00 6.81%
EXPENDITURE:
Increase/Decrease in Stock -24.70 -16.70 -47.90%
Raw Materials Consumed 413.20 589.50 -29.91%
Power & Fuel Cost 56.10 50.50 11.09%
Employee Cost 312.20 232.10 34.51%
Other Manufacturing Expenses 152.90 134.20 13.93%
General and Administration Expenses 96.00 78.30 22.61%
Selling and Distribution Expenses 98.00 128.80 -23.91%
Miscellaneous Expenses 59.20 69.30 -14.57%
Expenses Capitalised 0.00 0.00 0.00%
Total Expenditure 1,162.90 1,266.00 -8.14%
PBIDT (Excl OI) 928.40 692.00 34.16%
Other Income 39.40 13.20 198.48%
Operating Profit 967.80 705.20 37.24%
Interest 14.70 17.50 -16.00%
PBDT 953.10 687.70 38.59%
Depreciation 65.50 53.60 22.20%
Profit Before Taxation & Exceptional Items 887.60 634.10 39.98%
Exceptional Income / Expenses 0.00 0.00 0.00%
Profit Before Tax 887.60 634.10 39.98%
Provision for Tax 189.40 139.30 35.97%
PAT 698.20 494.80 41.11%
Extraordinary Items 0.00 0.00 0.00%
Adj to Profit After Tax 0.00 0.00 0.00%
Profit Balance B/F 954.40 601.20 58.75%
Appropriations 1,652.60 1,096.00 50.78%
Equity Dividend (%) 412.50 337.50 22.22%
Earnings Per Share (in ₹) 37.84 28.36 33.46%
Book Value (in ₹) 168.09 96.52 74.14%
Top